How much does stem cell therapy for Heart Failure & Cardiac Repair cost? (2026)
The comparison dataset stores a Bulgaria planning observation of €3,000–€8,000 for treatment, compiled from cited public commercial sources. It is not a quotation from Stem Plus, and different products, doses, visits and inclusions must not be treated as equivalent. The stored registry query contains 125 Heart Failure & Cardiac Repair records. Registration does not mean that a study is recruiting, that a person is eligible, or that treatment and travel are free; verify the current record and sponsor-cost terms directly.
Heart failure is a clinical syndrome in which impaired cardiac contraction, relaxation or both causes symptoms and circulatory dysfunction. Causes include myocardial infarction, hypertension, cardiomyopathy and valvular disease. Mesenchymal stromal cells (MSCs) and extracellular vesicles are being studied for possible effects on inflammation, fibrosis, angiogenesis and cell survival observed mainly in preclinical models. Those mechanisms have not established clinically meaningful cardiac repair in people. The registry table on this page lists relevant studies and their current recruitment status.
What drives the cost for Heart Failure & Cardiac Repair
Private investigational heart-failure cell procedures can involve separate charges for catheterisation, imaging, laboratory testing, monitoring, travel and standard cardiology care. Prices do not indicate regulatory approval or expected benefit, and repeat dosing is not an established standard. Patients should request an itemised written quote and verify which costs are paid by the study sponsor, insurer and patient. Guideline-directed heart-failure treatment and transplant or device evaluation must not be delayed for an experimental procedure.
Human heart-failure cell-therapy studies vary substantially by cell product, ischaemic or non-ischaemic cause, route, comparator and endpoint. Some studies report changes in imaging, exercise capacity or biomarkers, but consistent improvement in hospitalisation or survival has not been established for a marketed cell product. Exploratory subgroup findings should not be converted into a predictable response rate. No pooled response rate is published here because the studies are too heterogeneous for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Heart Failure & Cardiac Repair cost by country — comparison (2026)
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | Verify provider and laboratory certificates |
| USA | €4,600–€46,000 | Non-EU; verify provider and product status |
| UK | €4,880–€49,000 | Non-EU; verify provider and product status |
| Germany | €11,000–€36,700 | EU member state; verify provider and product status |
| Switzerland | €20,000–€40,000 | Non-EU; verify provider and product status |
| Mexico | €3,000–€12,000 | Non-EU; verify provider and product status |
| India | €3,000–€8,000 | Non-EU; verify provider and product status |
| Serbia | €7,000–€31,000 | Non-EU; verify provider and product status |
| Turkey | €6,000–€18,000 | Non-EU; verify provider and product status |
| Thailand | €8,000–€20,000 | Non-EU; verify provider and product status |
| Panama | €15,000–€27,000 | Non-EU; verify provider and product status |
Price varies with cell type, dose, number of sessions, diagnostics, supportive care and follow-up. A lower range does not establish equivalent quality or outcome. Request a fixed written quote and verify the therapy and provider with the relevant authorities. Check registered trials before paying privately.
Heart Failure & Cardiac Repair cost — common questions
Why is Heart Failure & Cardiac Repair stem-cell treatment so much cheaper in Bulgaria?
The collected commercial ranges differ, but they may describe different products, doses, visits and inclusions. A lower quote does not establish equivalent quality, evidence or regulatory status.
Is a cheaper programme riskier?
Price alone cannot establish risk. Verify the exact treatment status, provider and manufacturing authorisations, product identity, release testing, adverse-event plan and primary evidence.
Does the price include travel and hotel?
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
Will I get a fixed quote, or an open-ended bill?
Ask for a written quotation after clinical review, with the exact product, inclusions, exclusions, cancellation terms and circumstances in which charges may change. A website estimate is not a binding quote.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for Heart Failure & Cardiac Repair (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.